Global Acute Ischemic Stroke Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147219
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 135
  • list Pharmaceuticals and Healthcare

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.

Scope of the Report:

This report focuses on the Acute Ischemic Stroke Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Technavio's analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2025.

The worldwide market for Acute Ischemic Stroke Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Bayer

Boehringer Ingelheim

Roche

Sanofi

Biogen

Daiichi Sankyo

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Thrombolytic Therapeutics

Antihypertensive Therapeutics

Antiplatelet Therapeutics

Anticoagulants

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Center

Diagnostic Centers

There are 15 Chapters to deeply display the global Acute Ischemic Stroke Therapeutics market.

Chapter 1, to describe Acute Ischemic Stroke Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Acute Ischemic Stroke Therapeutics, with sales, revenue, and price of Acute Ischemic Stroke Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Acute Ischemic Stroke Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Acute Ischemic Stroke Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Acute Ischemic Stroke Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Acute Ischemic Stroke Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Thrombolytic Therapeutics

1.2.2 Antihypertensive Therapeutics

1.2.3 Antiplatelet Therapeutics

1.2.4 Anticoagulants

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Ambulatory Surgical Center

1.3.3 Diagnostic Centers

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Bayer

2.1.1 Business Overview

2.1.2 Acute Ischemic Stroke Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bayer Acute Ischemic Stroke Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boehringer Ingelheim

2.2.1 Business Overview

2.2.2 Acute Ischemic Stroke Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Roche

2.3.1 Business Overview

2.3.2 Acute Ischemic Stroke Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Roche Acute Ischemic Stroke Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Acute Ischemic Stroke Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Acute Ischemic Stroke Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Biogen

2.5.1 Business Overview

2.5.2 Acute Ischemic Stroke Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Biogen Acute Ischemic Stroke Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Daiichi Sankyo

2.6.1 Business Overview

2.6.2 Acute Ischemic Stroke Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Acute Ischemic Stroke Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Acute Ischemic Stroke Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Acute Ischemic Stroke Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Acute Ischemic Stroke Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Acute Ischemic Stroke Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Acute Ischemic Stroke Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Acute Ischemic Stroke Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Acute Ischemic Stroke Therapeutics Market Analysis by Regions

4.1 Global Acute Ischemic Stroke Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Acute Ischemic Stroke Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Acute Ischemic Stroke Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

5 North America Acute Ischemic Stroke Therapeutics by Countries

5.1 North America Acute Ischemic Stroke Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Acute Ischemic Stroke Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Acute Ischemic Stroke Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Acute Ischemic Stroke Therapeutics by Countries

6.1 Europe Acute Ischemic Stroke Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Acute Ischemic Stroke Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Acute Ischemic Stroke Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Acute Ischemic Stroke Therapeutics by Countries

7.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Acute Ischemic Stroke Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

8 South America Acute Ischemic Stroke Therapeutics by Countries

8.1 South America Acute Ischemic Stroke Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Acute Ischemic Stroke Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Acute Ischemic Stroke Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Acute Ischemic Stroke Therapeutics by Countries

9.1 Middle East and Africa Acute Ischemic Stroke Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Acute Ischemic Stroke Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Acute Ischemic Stroke Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Acute Ischemic Stroke Therapeutics Sales and Growth Rate (2013-2018)

10 Global Acute Ischemic Stroke Therapeutics Market Segment by Type

10.1 Global Acute Ischemic Stroke Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Acute Ischemic Stroke Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Acute Ischemic Stroke Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Thrombolytic Therapeutics Sales Growth and Price

10.2.1 Global Thrombolytic Therapeutics Sales Growth (2013-2018)

10.2.2 Global Thrombolytic Therapeutics Price (2013-2018)

10.3 Antihypertensive Therapeutics Sales Growth and Price

10.3.1 Global Antihypertensive Therapeutics Sales Growth (2013-2018)

10.3.2 Global Antihypertensive Therapeutics Price (2013-2018)

10.4 Antiplatelet Therapeutics Sales Growth and Price

10.4.1 Global Antiplatelet Therapeutics Sales Growth (2013-2018)

10.4.2 Global Antiplatelet Therapeutics Price (2013-2018)

10.5 Anticoagulants Sales Growth and Price

10.5.1 Global Anticoagulants Sales Growth (2013-2018)

10.5.2 Global Anticoagulants Price (2013-2018)

11 Global Acute Ischemic Stroke Therapeutics Market Segment by Application

11.1 Global Acute Ischemic Stroke Therapeutics Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Ambulatory Surgical Center Sales Growth (2013-2018)

11.4 Diagnostic Centers Sales Growth (2013-2018)

12 Acute Ischemic Stroke Therapeutics Market Forecast (2018-2023)

12.1 Global Acute Ischemic Stroke Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Acute Ischemic Stroke Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Acute Ischemic Stroke Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Acute Ischemic Stroke Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Forecast (2018-2023)

12.2.4 South America Acute Ischemic Stroke Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Acute Ischemic Stroke Therapeutics Market Forecast (2018-2023)

12.3 Acute Ischemic Stroke Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Acute Ischemic Stroke Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Acute Ischemic Stroke Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Acute Ischemic Stroke Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Acute Ischemic Stroke Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Acute Ischemic Stroke Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Acute Ischemic Stroke Therapeutics Picture

Table Product Specifications of Acute Ischemic Stroke Therapeutics

Figure Global Sales Market Share of Acute Ischemic Stro

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery